Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
WinPro
1 other identifier
observational
120
2 countries
3
Brief Summary
Commonly, in clinical practice an automated analysis of pH-MII tracings is obtained.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 29, 2023
CompletedFirst Submitted
Initial submission to the registry
October 2, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMarch 19, 2025
March 1, 2025
2.5 years
October 2, 2023
March 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Statistical difference in the GERD categorisation
the statistical difference in the distribution of GERD categorisation between automated vs. manual review of the pH-MII tracings
During baseline visit
Secondary Outcomes (8)
The analysis of the influence of different parameters on application of the Wingate criteria: including the Indication for referral with further classification into predominant oesophageal and extra-oesophageal symptoms;
During baseline visit
The analysis of the influence of different parameters on application of the Wingate criteria: including the GERD Symptom Severity;
During baseline visit
The analysis of the influence of different parameters on application of the Wingate criteria: including the patient being on or off PPI;
During baseline visit
The analysis of the influence of different parameters on application of the Wingate criteria: including MNBI (obtained by automated analysis or manually calculated);
During baseline visit
Presence of significant correlations between censored episodes and pH-MII parameters
During baseline visit
- +3 more secondary outcomes
Study Arms (1)
GERD patients
Interventions
Eligibility Criteria
All patients referred for pH-MII are eligible.
You may qualify if:
- Adult patients aged 18 - 80 years old;
- pH-MII performed off PPI
You may not qualify if:
- Prior upper GI endoscopy indicative of structural disease (except for oesophagitis or hiatal hernia).
- Incomplete pH-MII (less than 21 hours recording);
- Ph-MII performed on PPI
- Suboptimal quality of the tracings preventing interpretation in clinical practice;
- Prior oesophageal (including anti-reflux intervention) or gastric surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
H.U.B
Anderlecht, 1080, Belgium
UZ Brussel
Jette, 1090, Belgium
Technische Universität München
München, 81675, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2023
First Posted
October 16, 2023
Study Start
September 29, 2023
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
March 19, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share